Semax Nasal Spray: Regulatory Status and Clinical Applications

Regulatory Status and Evidence Quality

The American Academy of Otolaryngology and the European Rhinologic Society do not recommend Semax due to its lack of FDA approval and limited high-quality evidence 1, 2, 3, 4
The available studies on Semax have significant methodological limitations, including small sample sizes and incomplete methodological details, as noted by the American College of Physicians 1
No large-scale, multicenter, placebo-controlled trials meeting modern regulatory standards have been published for Semax, according to the American Academy of Neurology 2

The American Academy of Otolaryngology recommends following standard nasal spray technique principles if Semax is encountered in practice, including priming and shaking the bottle before use, keeping the head upright during administration, using contralateral hand technique, and breathing in gently during spraying 1, 3, 4
Patients inquiring about Semax should be counseled about the absence of regulatory approval and the limited, non-replicated evidence base, as advised by the American Medical Association 1, 2, 3, 4